Is chemotherapy the standard for asymptomatic androgen-independent prostate cancer?

@article{Nabhan2008IsCT,
  title={Is chemotherapy the standard for asymptomatic androgen-independent prostate cancer?},
  author={Chadi Nabhan},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2008},
  volume={26 14},
  pages={2413-4; author reply 2414-5}
}
tions such as symptomatic elderly patients who have del(17p13.1). Furthermore, we do not believe alemtuzumab should be used in any case for eradication of minimal residual disease after initial induction therapy with alternative CLL agents outside of an institutional review board–approved clinical trial. The major focus of our editorial was to initiate… CONTINUE READING